Urolithin A, explained

Urolithin A is one of those molecules that sounds like marketing invented it. It didn't. It's a real metabolite with a genuinely interesting back-story: your body can't produce it, your gut produces it for you, and what it does inside cells has been studied in randomised human trials. Here is the whole picture, with the honest edges left on.

What it actually is

Urolithin A is a small compound produced when gut microbes break down a family of large polyphenols called ellagitannins. You don't get urolithin A by eating it — there's essentially none in food. You get it by eating ellagitannin-rich foods, chiefly pomegranate, and also raspberries, walnuts and other berries, and letting your gut bacteria do the conversion.

That's the catch worth knowing up front: not everyone's gut microbiome can make it efficiently. The conversion depends on having the right microbial community, which is part of why the same pomegranate produces very different urolithin A levels in different people.

How the gut makes it

The pathway runs in steps:

• You eat ellagitannins (for example, punicalagin from pomegranate).
• In the gut, these are hydrolysed to ellagic acid.
• Specific gut microbes then convert ellagic acid, through several intermediates, into urolithin A.

There's an Akkermansia connection at the front of this chain, too. In a 2017 study, pomegranate ellagitannins stimulated the growth of Akkermansia muciniphila in vivo (Henning et al., 2017) — so the same dietary polyphenols that supply the substrate for urolithin A are also linked to the bacterium we build around. It's one of the more carefully traced food-to-microbe-to-metabolite pathways in nutrition science.

The mitophagy research

The reason urolithin A drew serious scientific attention is mitophagy — the cell's housekeeping process for recycling worn-out mitochondria, the energy plants inside your cells. As mitochondria age, clearing the damaged ones matters for how cells function.

In 2016, Dongryeol Ryu and colleagues showed that urolithin A induced mitophagy and extended lifespan in the worm C. elegans, and improved muscle function in rodents (Ryu et al., 2016). That's a striking result — but read the model honestly: it's an invertebrate and rodent study. Lifespan extension in a worm is a real finding about a molecule; it is not a statement about people.

The barrier research

There's a second strand worth knowing, because it bridges the longevity story to the gut. In 2019, Rajbir Singh and colleagues showed that urolithin A enhanced gut-barrier integrity through the Nrf2 pathway in laboratory and mouse models (Singh et al., 2019) — the same barrier Akkermansia helps maintain. So urolithin A isn't only a mitochondrial story; it touches the gut lining as well.

The human trials

This is where urolithin A stands apart from most "longevity" ingredients: it's been tested in people.

• In a first-in-human trial, urolithin A was safe and produced a molecular signature of improved mitochondrial and cellular health in older adults (Andreux et al., 2019).
• In a randomised, placebo-controlled trial in middle-aged adults, it improved muscle endurance and biomarkers of mitochondrial health (Singh et al., 2022).
• A 2024 systematic review pulled the human evidence together and assessed where it stands (Kuerec et al., 2024).

These are real, well-conducted trials — and they're also specific. They measured biomarkers, muscle endurance, and safety, not "aging" as an outcome. That distinction is the whole game.

The honest part

We don't make anti-aging, lifespan, or disease claims — for urolithin A or for our product (here's why). The mitophagy-and-lifespan work is largely in cells and animals; the human trials are encouraging but narrow in scope, focused on defined biomarkers and muscle endpoints. "Studied for its role in mitochondrial health" is true; "reverses aging" is not.

What we can say: urolithin A is a microbe-made metabolite with an unusually well-mapped pathway and genuine human-trial data behind it. That's why pomegranate — the ellagitannin source the literature ties most directly to both Akkermansia and urolithin A — anchors Vekovia · Pomegranate, our longevity-leaning pairing.